XiangDaDongMD
General Surgery • Valhalla, NYEndocrine, Hepatobiliary Surgery, Surgical Oncology (Other than Breast), Minimally Invasive Surgery
Clinical Associate Professor of Surgery
Dr. Dong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
100 Woods Rd
Valhalla, NY 10595Phone+1 914-909-9018Fax+1 914-493-2267
Summary
- Xiang Da (Eric) Dong, MD, FACS, a fellowship-trained surgical oncologist, has joined the medical staff at Nuvance Health at Norwalk Hospital and Danbury Hospital as Chief of Surgical Oncology / Hepatobiliary Surgery. Dr. Dong specializes in the treatment of gastrointestinal cancer, including colorectal, esophageal, gastric, liver and pancreatic cancer. He’s also actively involved in the management of patients with endocrine disorders.
Dr. Dong is interested in minimally invasive surgery for gastrointestinal malignancies. He has authored over 50 peer reviewed papers on various topics regarding cancer. He is also interested in robotic surgery, for management of gastric, intestinal, pancreatic, rectal and other intra-abdominal malignancies.
Education & Training
UPMC Medical EducationFellowship, Complex General Surgical Oncology, 2004 - 2007
Drexel University College of Medicine/Hahnemann University HospitalResidency, Surgery, 2000 - 2004
Yale-New Haven Medical CenterInternship, Transitional Year, 1999 - 2000
Duke University School of MedicineClass of 1999
Certifications & Licensure
NY State Medical License 2010 - 2026
CT State Medical License 2007 - 2025
PA State Medical License 2001 - 2024
OH State Medical License 2015 - 2017- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Connecticut Magazine 2022
- New York Magazine: Top Doctor 2021-2022
- Top Doctors: New York Metro Area Castle Connolly, 2016-2022
- Join now to see all
Publications & Presentations
PubMed
- 100 citationsRole of MicroRNA-182 in Posterior Uveal Melanoma: Regulation of Tumor Development through MITF, BCL2 and Cyclin D2Dongsheng Yan, Xiang Da Dong, Xiaoyan Chen, Shasha Yao, Lihua Wang
Plos One. 2012-07-27 - 161 citationsMicroRNA-34a Inhibits Uveal Melanoma Cell Proliferation and Migration through Downregulation of c-MetDongsheng Yan, Xiangtian Zhou, Xiaoyan Chen, Dan-Ning Hu, Xiang Da Dong
Investigative Ophthalmology & Visual Science. 2009-04-01 - 69 citationsMicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.Xiaoyan Chen, Dandan He, Xiang Da Dong, Feng Dong, Jiao Wang
Investigative Ophthalmology & Visual Science. 2013-03-01
Professional Memberships
- Fellow
- Member
- International Hepato-Pancreatico-Biliary AssociationMember
- Society of Robotic SurgeryMember
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
